GoKawiilEvvy secures $40M Series B to expand vaginal microbiome testing and research
Evvy, a women's health startup, has closed a $40 million Series B funding round led by Catalio Capital Management. The company operates an at-home vaginal microbiome test that uses mNGS sequencing, serving over 100,000 patients and 3,000 practitioners across the US, and has produced 15 peer-reviewed publications from its data.